|
US6150328A
(en)
|
1986-07-01 |
2000-11-21 |
Genetics Institute, Inc. |
BMP products
|
|
US6291206B1
(en)
|
1993-09-17 |
2001-09-18 |
Genetics Institute, Inc. |
BMP receptor proteins
|
|
ES2255059T3
(es)
|
1993-12-07 |
2006-06-16 |
Genetics Institute, Llc |
Bmp-12, bmp-13 y composiciones suyas inductoras de tendon.
|
|
AU4409899A
(en)
*
|
1998-05-28 |
1999-12-13 |
Board Of Trustees Of The University Of Arkansas, The |
Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
|
|
IL143266A0
(en)
*
|
1998-11-27 |
2002-04-21 |
Darwin Discovery Ltd |
Transforming growth factor-beta binding proteins and pharmaceutical compositions for increasing bone mineral content utilizing the same
|
|
US6727224B1
(en)
|
1999-02-01 |
2004-04-27 |
Genetics Institute, Llc. |
Methods and compositions for healing and repair of articular cartilage
|
|
ATE271886T1
(de)
|
1999-10-15 |
2004-08-15 |
Inst Genetics Llc |
Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine
|
|
DE60226321T2
(de)
|
2001-06-01 |
2009-07-09 |
Wyeth |
Zusammensetzungen für die systemische verabreichung von sequenzen, die für knochenmorphogenese-proteinen kodieren
|
|
EP1402073B1
(en)
*
|
2001-06-05 |
2007-02-14 |
Auckland Uniservices Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
|
IL159240A0
(en)
*
|
2001-06-08 |
2004-06-01 |
Smith & Nephew |
Bmp binding proteins for use in bone or cartilage regeneration
|
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
|
GB2385052A
(en)
|
2002-02-05 |
2003-08-13 |
Leuven K U Res & Dev |
Treatment of spondyloarthropathies
|
|
US7193069B2
(en)
*
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
WO2004062621A2
(en)
*
|
2003-01-13 |
2004-07-29 |
Georgia Tech Research Corporation |
Anti-inflammatory agents and methods of their use
|
|
JP2008500373A
(ja)
*
|
2004-05-27 |
2008-01-10 |
アクセルロン ファーマ インコーポレーテッド |
ケルベロス（Ｃｅｒｂｅｒｕｓ）／ココ（Ｃｏｃｏ）誘導体およびそれらの使用
|
|
US9045553B2
(en)
|
2004-05-27 |
2015-06-02 |
Acceleron Pharma, Inc. |
Cerberus/Coco derivatives and uses thereof
|
|
WO2006121351A2
(en)
*
|
2005-05-10 |
2006-11-16 |
Synergenz Bioscience Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
|
KR20080011292A
(ko)
*
|
2005-05-19 |
2008-02-01 |
시너젠즈 바이오사이언스 리미티드 |
유전자 다형 분석을 사용하여 폐암 발생 위험을 평가하는방법
|
|
WO2006123954A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
|
US7933722B2
(en)
*
|
2005-05-20 |
2011-04-26 |
Synergenz Bioscience Limited |
Methods of analysis of polymorphisms and uses thereof
|
|
US20090298761A1
(en)
*
|
2006-05-17 |
2009-12-03 |
Donald Engelman |
Methods of treating cartilage defects using a soluble morphogenic protein complex
|
|
JP2010512326A
(ja)
*
|
2006-12-08 |
2010-04-22 |
アクセルロン ファーマ， インコーポレイテッド |
Ｃｅｒｂｅｒｕｓ、Ｃｏｃｏおよびこれらの誘導体の使用
|
|
CN105759056B
(zh)
*
|
2016-04-06 |
2017-11-14 |
四川大学华西医院 |
一种肺癌筛查试剂盒
|
|
WO2018115879A1
(en)
|
2016-12-21 |
2018-06-28 |
Mereo Biopharma 3 Limited |
Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
|